Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1998 2
2020 2
2021 4
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Extramedullary Plasmacytoma Mimicking Gallbladder Cancer.
Nishimura N, Ono Y, Shirouchi Y, Maruyama D. Nishimura N, et al. Among authors: shirouchi y. Intern Med. 2023 Sep 1;62(17):2581-2582. doi: 10.2169/internalmedicine.1079-22. Epub 2022 Dec 14. Intern Med. 2023. PMID: 36517034 Free PMC article. No abstract available.
Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.
Shirouchi Y, Nishimura N, Mishima Y, Ishihara Y, Asai H, Tamba M, Hirano M, Hirano K, Teramoto Y, Yoshida K, Takeuchi K, Terauchi T, Maruyama D. Shirouchi Y, et al. Sci Rep. 2023 Aug 22;13(1):13713. doi: 10.1038/s41598-023-40026-7. Sci Rep. 2023. PMID: 37608029 Free PMC article.
Durable response of therapy-related MDS/AML with concomitant Waldenström's macroglobulinemia treated with venetoclax and azacitidine.
Hirano M, Tamba M, Inoue N, Ikegami M, Onda N, Shirouchi Y, Ishihara Y, Abe H, Nishimura N, Mishima Y, Takeuchi K, Maruyama D. Hirano M, et al. Among authors: shirouchi y. Ann Hematol. 2022 Jul;101(7):1587-1589. doi: 10.1007/s00277-022-04777-z. Epub 2022 Feb 21. Ann Hematol. 2022. PMID: 35187605 Free PMC article. No abstract available.
The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y, Mishima Y, Shirouchi Y, Nishimura N, Yokoyama M, Okabe T, Inoue N, Uryu H, Fukuta T, Hatake K, Terui Y. Mishima Y, et al. Among authors: shirouchi y. Int J Hematol. 2021 Feb;113(2):279-284. doi: 10.1007/s12185-020-02979-7. Epub 2020 Aug 30. Int J Hematol. 2021. PMID: 32864713
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma.
Uryu H, Mishima Y, Tsuyama N, Yokoyama M, Nishimura N, Fukuta T, Shirouchi Y, Okabe T, Inoue N, Takeuchi K, Terui Y. Uryu H, et al. Among authors: shirouchi y. Leuk Lymphoma. 2021 Sep;62(9):2141-2150. doi: 10.1080/10428194.2021.1901091. Epub 2021 Mar 21. Leuk Lymphoma. 2021. PMID: 33749498
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population.
Shirouchi Y, Yokoyama M, Fukuta T, Uryu H, Nishimura N, Mishima Y, Inoue N, Tsuyama N, Takeuchi K, Terui Y. Shirouchi Y, et al. Leuk Lymphoma. 2021 Aug;62(8):1869-1876. doi: 10.1080/10428194.2021.1894649. Epub 2021 Mar 10. Leuk Lymphoma. 2021. PMID: 33688781
13 results